KL
KCK Ltd Portfolio holdings
AUM
$18.3M
This Quarter Return
+38.65%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$75M
AUM Growth
–
Cap. Flow
+$75M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Neuropace
NPCE
|
$59M |
| 2 |
Sight Sciences
SGHT
|
$15.9M |
| 3 |
RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
|
$51.4K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Neuropace
NPCE
$302M
| $59M | 78.69% |
+5,270,845
| New | +$59M |
|
|
2
Sight Sciences
SGHT
$203M
| $15.9M | 21.25% |
+4,374,975
| New | +$15.9M |
|
|
RNTX
3
Rein Therapeutics, Inc. Common Stock
RNTX
$31.1M
| $51.4K | 0.07% |
+22,341
| New | +$51.4K |
|